Impella protected percutaneous coronary intervention on the last remaining highly calcified coronary artery facilitated by shockwave intravascular lithotripsy and levosimendan infusion
Kardiol Pol
.
2021;79(10):1145-1146.
doi: 10.33963/KP.a2021.0062.
Epub 2021 Jul 16.
Authors
Piotr Rola
1
2
,
Adrian Włodarczak
3
,
Artur Jastrzębski
3
,
Mateusz Barycki
4
,
Karol Turkiewicz
3
,
Jan Jakub Kulczycki
3
,
Marek Szudrowicz
3
,
Maciej Pęcherzewski
3
,
Adrian Doroszko
5
,
Maciej Lesiak
6
Affiliations
1
Department of Cardiology, The Copper Health Center, Lubin, Poland. piotr.rola@gmail.com.
2
Department of Cardiology, Provincial Specialized Hospital in Legnica, Poland. piotr.rola@gmail.com.
3
Department of Cardiology, The Copper Health Center, Lubin, Poland.
4
Department of Cardiology, Provincial Specialized Hospital in Legnica, Poland.
5
Department of Internal Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Wrocław, Poland.
6
1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.
PMID:
34268721
DOI:
10.33963/KP.a2021.0062
No abstract available
MeSH terms
Coronary Vessels
Humans
Lithotripsy*
Percutaneous Coronary Intervention*
Simendan
Substances
Simendan